Genzyme Financial Statements
Genzyme Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
| Annual Report | Company Web Site |
| Investor Relations | Company Web Site |
This data is provided as per license from EDGAR Online
Genzyme Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 3,813.5 | 3,187.0 | 2,734.8 |
| Gross Profit ($ mil.) | 2,886.2 | 2,451.3 | 2,102.2 |
| Operating Income ($ mil.) | 653.9 | (190.5) | 600.9 |
| Total Net Income ($ mil.) | 480.2 | (16.8) | 441.5 |
| Diluted EPS (Net Income) | 1.74 | (0.06) | 1.65 |
Genzyme Quarterly Statements
| Quarter Ending Jun 08 | Quarter Ending Mar 08 | Quarter Ending Dec 07 | |
|---|---|---|---|
| Revenue ($ mil.) | 1,171.1 | 1,100.1 | 1,036.8 |
| Gross Profit ($ mil.) | 870.8 | 827.8 | 774.1 |
| Operating Income ($ mil.) | 86.0 | 190.9 | 110.3 |
| Total Net Income ($ mil.) | 69.6 | 145.3 | 78.9 |
| Diluted EPS (Net Income) | 0.25 | 0.52 | 0.29 |
Genzyme Stock Quote & Chart
10/13/08 15:00:28 EST •
NASDAQ •
73.17
•
 0.0000
•
0.0000 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Genzyme Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 5.23 | 3.75 | 1.56 |
| Price/Earnings Ratio | 48.86 | 16.34 | 15.82 |
| Price/Book Ratio | 3.17 | 2.92 | 1.52 |
| Price/Cash Flow Ratio | 30.91 | 13.17 | 9.88 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Genzyme Financial Ratios
Genzyme Competitive Intelligence
| Johnson & Johnson | Shire | UCB | |
|---|---|---|---|
| Annual Sales ($ mil.) | 61,095.0 | -- | 3,328.6 |
| Employees | -- | 103 | 8,477 |
| Market Cap ($ mil.) | 199,077.4 | -- | -- |
Competitive Landscape
